| Name | Vatelizumab |
|---|
| Description | Vatelizumab (GBR500) is a monoclonal antibody targeting the α2 subunit (CD49b) of very late antigen-2 (VLA-2). Vatelizumab can be used for the research of multiple sclerosis[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |